34.2 Acute Constipation & Functional Bowel Changes

ABFM Family Medicine Certification Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Blueprint & Clinical Decision-Making

1.1 Exam Blueprint, FMCLA vs. One-Day Exam & Board Scoring 1.2 Clinical Reasoning, Test-Taking Strategy & Ambiguity Management 1.3 Evidence-Based Medicine & Clinical Practice Guidelines in Primary Care

2 Chapter 2: Healthcare Systems, Practice Management & Quality

2.1 Practice Management, Billing, Coding & Documentation 2.2 Quality Improvement, Patient Safety & Diagnostic Stewardship 2.3 Interprofessional Team-Based Care & Care Coordination

3 Chapter 3: Ethics, Law, Biostatistics & Health Equity

3.1 Medical Ethics, Informed Consent & Surrogate Decision-Making 3.2 Biostatistics, Clinical Epidemiology & Diagnostic Test Interpretation 3.3 Social Determinants of Health, Health Equity & Cultural Humility 3.4 Physician Wellness, Burnout Prevention & Professionalism

4 Chapter 4: Lifestyle Counseling & Behavior Change

4.1 Alcohol Use Screening & Brief Intervention 4.2 Illicit Drug & Cannabis Counseling 4.3 Tobacco & Vaping Cessation Counseling

5 Chapter 5: Nutrition, Physical Activity & Chronic Disease Prevention

5.1 Dietary Counseling for Obesity & Chronic Disease Prevention 5.2 Exercise Prescription & Physical Activity Counseling 5.3 Genetic Risk Assessment & Family History Counseling

6 Chapter 6: Routine Adult Immunizations

6.1 ACIP Adult Respiratory Vaccines: Influenza, COVID-19, RSV & Pneumococcal 6.2 ACIP Adult Non-Respiratory Vaccines: Tdap, Shingrix, HPV & Hep B 6.3 Immunizations in Special Populations: Pregnancy, Asplenia & Immunocompromise

7 Chapter 7: Pediatric Health Maintenance & Surveillance

7.1 Newborn Examination & Early Postnatal Care 7.2 Well-Child Care, Developmental Surveillance & Milestones 7.3 Pediatric & Adolescent Screening: Vision, Hearing, Anemia & Lead 7.4 Pediatric Oral Health, Dental Screening & Fluoride

8 Chapter 8: Behavioral Health & Safety Screening

8.1 Primary Care Depression, Anxiety & Behavioral Health Screening 8.2 Domestic Violence, Intimate Partner Violence & Firearm Safety 8.3 Occupational Health & Recreational Safety Counseling

9 Chapter 9: Adult Preventive Screening: Cardiovascular & Metabolic

9.1 Cardiovascular Disease & Hypertension Screening 9.2 Type 2 Diabetes Screening & Prediabetes Risk Stratification 9.3 Abdominal Aortic Aneurysm & Osteoporosis Screening

10 Chapter 10: Adult Cancer Screening: Breast & Gynecologic

10.1 Breast Cancer Screening & Risk-Assessment 10.2 Cervical Cancer Screening & ASCCP Algorithms 10.3 Skin Cancer Clinical Assessment & Counseling

11 Chapter 11: Adult Cancer Screening: Colorectal, Lung & Prostate

11.1 Colorectal Cancer Screening Modalities & Intervals 11.2 Lung Cancer Screening with Low-Dose CT 11.3 Prostate Cancer Screening & Shared Decision-Making

12 Chapter 12: Sexual Health, Infectious Disease Screening & Contraception

12.1 Sexual Health Counseling & Risk-Reduction Strategies 12.2 STI Screening: Chlamydia, Gonorrhea, Syphilis & Trichomoniasis 12.3 Bloodborne Infectious Disease Screening: HIV & Hepatitis C

13 Chapter 13: Reproductive Life Planning, Lactation & Preoperative Care

13.1 Preconception Planning & Comprehensive Contraception Management 13.2 Lactation Support & Breastfeeding Counseling 13.3 Preoperative Medical Evaluation & Pre-Participation Sports Exam

14 Chapter 14: Emergent Cardiovascular Conditions

14.1 Acute Coronary Syndromes & Myocardial Infarction 14.2 Acute Chest Pain Risk Stratification & Triage 14.3 Acute or Critical Valvular Heart Emergencies

15 Chapter 15: Cardiac Arrhythmias, Heart Failure & Hypertensive Crises

15.1 Acute Atrial & Ventricular Arrhythmias 15.2 Acute Decompensated Heart Failure & Cardiogenic Shock 15.3 Hypertensive Emergency & Urgency Management

16 Chapter 16: Vascular & Thromboembolic Emergencies

16.1 Pulmonary Embolism & Deep Vein Thrombosis 16.2 Acute Aortic Syndromes & Peripheral Vascular Emergencies 16.3 Critical Limb Ischemia & Acute Arterial Occlusion

17 Chapter 17: Neurologic Emergencies: Stroke & Altered Consciousness

17.1 Acute Ischemic Stroke & Intracranial Hemorrhage 17.2 Syncope Evaluation & Status Epilepticus 17.3 Acute Delirium, Encephalopathy & Severe Confusion

18 Chapter 18: Neurologic Trauma & Acute Cranial Emergencies

18.1 Concussion, Moderate-to-Severe TBI & Intracranial Injury 18.2 Thunderclap & Acute Severe Secondary Headaches 18.3 Acute Ophthalmologic Emergencies

19 Chapter 19: Acute Abdominal, Pelvic & Gastrointestinal Emergencies

19.1 Acute Abdominal & Pelvic Pain Triage 19.2 Upper & Lower Gastrointestinal Bleeding 19.3 Acute Hepatic Failure, Cholangitis & Severe Jaundice

20 Chapter 20: Acute Pulmonary & Airway Emergencies

20.1 Acute Hypoxic Respiratory Failure & ARDS 20.2 Severe Community-Acquired Pneumonia & Empyema 20.3 Acute Severe Epistaxis & Airway Obstruction

21 Chapter 21: Acute Traumatic Injuries & Wound Care

21.1 Major Trauma Resuscitation & Initial Assessment 21.2 Burn Assessment, Inhalation Injury & Resuscitation 21.3 Laceration Management, Complex Wounds & Animal Bites

22 Chapter 22: Acute Orthopedic & Musculoskeletal Emergencies

22.1 Acute Ambulatory Fractures & Initial Splinting 22.2 Compartment Syndrome & Major Orthopedic Trauma 22.3 Septic Arthritis & Acute Microcrystalline Crises

23 Chapter 23: Severe Infections, Sepsis & Systemic Emergencies

23.1 Sepsis, Septic Shock & Initial Fluid Resuscitation 23.2 Necrotizing Soft Tissue Infections & Severe CNS Infections 23.3 Anaphylaxis Diagnosis, Epinephrine Dosing & Airway Protection

24 Chapter 24: Metabolic, Endocrine & Electrolyte Emergencies

24.1 Diabetic Ketoacidosis & Hyperosmolar Hyperglycemic State 24.2 Critical Electrolyte Emergencies: Dyskalemias & Dysnatremias 24.3 Severe Calcium Abnormalities & Acute Adrenal Crisis

25 Chapter 25: Hematologic, Urologic & Dental Emergencies

25.1 Severe Symptomatic Anemias & Coagulopathic Emergencies 25.2 Testicular Torsion, Priapism & Acute Urinary Retention 25.3 Urgent Odontogenic Infections & Dental Trauma

26 Chapter 26: Psychiatric, Behavioral & Obstetric/Gynecologic Emergencies

26.1 Suicidal Ideation, Acute Agitation & Behavioral Emergencies 26.2 Acute Physical & Sexual Assault Care 26.3 Life-Threatening Vaginal Bleeding & Ectopic Pregnancy 26.4 Environmental Heat Stroke & Severe Hypothermia

27 Chapter 27: Acute Head, Neck & Neurologic Symptoms

27.1 Primary Acute Headaches: Migraine, Tension & Cluster 27.2 Concussion & Minor Closed Head Injury Evaluation 27.3 Transient Ischemic Attack Evaluation & ABCD2 Risk Scoring

28 Chapter 28: Acute Cranial Nerves, Hearing & Sensory Symptoms

28.1 Peripheral Neuropathies: Bell's Palsy, Carpal Tunnel & Radiculopathy 28.2 Acute Tinnitus, Sudden Sensorineural Hearing Loss & Cerumen Impaction 28.3 Acute Dizziness, Benign Paroxysmal Positional Vertigo & Vestibular Neuritis

29 Chapter 29: Acute Upper Respiratory Tract Infections

29.1 Acute Viral Rhinosinusitis vs. Bacterial Rhinosinusitis 29.2 Acute Pharyngitis: Group A Streptococcus & Centor Criteria 29.3 Acute Otitis Media, Otitis Externa & Serous Effusion

30 Chapter 30: Acute Lower Respiratory Infections & Cough

30.1 Influenza, COVID-19 & Viral Respiratory Syndromes 30.2 Acute Bronchitis & Lower Respiratory Tract Infections 30.3 Ambulatory Community-Acquired Pneumonia

31 Chapter 31: Allergic, Nasal & Non-Infectious Pulmonary Conditions

31.1 Allergic Rhinitis & Acute Non-Anaphylactic Allergic Reactions 31.2 Acute Dyspnea in Ambulatory Care 31.3 Interstitial Lung Diseases & Sarcoidosis Presentation

32 Chapter 32: Acute Chest, Cardiac & Vascular Symptoms

32.1 Palpitations Evaluation & Arrhythmia Triage in Primary Care 32.2 Deep Vein Thrombosis & Superficial Thrombophlebitis 32.3 Ambulatory Hypotension & Orthostasis Evaluation

33 Chapter 33: Acute Upper Gastrointestinal Conditions

33.1 Peptic Ulcer Disease & Gastritis 33.2 Dysphagia, Esophagitis & Acute Esophageal Disorders 33.3 Acute Nausea, Vomiting & Foodborne Illness

34 Chapter 34: Acute Lower Gastrointestinal Conditions

34.1 Acute Infectious Diarrhea & Gastroenteritis 34.2 Acute Constipation & Functional Bowel Changes 34.3 Ano-Rectal Disorders: Hemorrhoids, Fissures, Abscesses & Pruritus Ani

35 Chapter 35: Inflammatory, Functional & Malabsorptive GI Disorders

35.1 Acute Flares of Inflammatory Bowel Disease 35.2 Irritable Bowel Syndrome: Diagnosis, Subtyping & Management 35.3 Celiac Disease & Malabsorption Syndromes

36 Chapter 36: Acute Abdominal, Hepatic & Biliary Disorders

36.1 Ambulatory Abdominal & Pelvic Pain Triage 36.2 Acute Cholecystitis, Biliary Colic & Pancreatitis 36.3 Acute Liver Injury & Viral Hepatitis

37 Chapter 37: Acute Abdominal Wall, Hernias & Dental Conditions

37.1 Abdominal Wall, Inguinal & Ventral Hernias 37.2 Acute Dental Pain, Odontogenic Abscess & Aphthous Ulcers 37.3 Acute Edema: Unilateral vs. Bilateral Diagnostic Evaluation

38 Chapter 38: Acute Infectious Dermatoses

38.1 Bacterial Skin Infections: Impetigo, Cellulitis & Cutaneous Abscesses 38.2 Fungal Skin Infections: Tinea Corporis, Cruris, Pedis & Onychomycosis 38.3 Viral Cutaneous Infections: Herpes Simplex, Zoster & Molluscum Contagiosum

39 Chapter 39: Inflammatory, Allergic & Autoimmune Dermatoses

39.1 Atopic Dermatitis, Contact Dermatitis & Eczematous Flares 39.2 Non-Infectious Rashes: Urticaria, Drug Eruptions & Erythema Multiforme 39.3 Cutaneous Malignancies & Premalignant Lesions: AK, BCC, SCC & Melanoma

40 Chapter 40: Acute Shoulder, Elbow & Upper Extremity Injuries

40.1 Rotator Cuff Pathology, Tendinopathy & Shoulder Impingement 40.2 Lateral & Medial Epicondylitis, Olecranon Bursitis & Elbow Sprains 40.3 Wrist & Hand Soft-Tissue Injuries: De Quervain, TFCC & Finger Sprains

41 Chapter 41: Acute Knee, Ankle & Lower Extremity Injuries

41.1 Meniscal Tears, Ligamentous Knee Injuries & Patellofemoral Pain 41.2 Ankle Sprains, Ottawa Ankle Rules & Achilles Tendinopathy 41.3 Plantar Fasciitis, Shin Splints & Overuse Syndromes

42 Chapter 42: Acute Ambulatory Fractures & Dislocations

42.1 Distal Radius, Scaphoid & Common Upper Extremity Fractures 42.2 Metatarsal, Clavicle & Common Lower Extremity Fractures 42.3 Joint Dislocation Management: Nursemaid's Elbow & Shoulder Subluxation

43 Chapter 43: Acute Axial Musculoskeletal Pain & Falls

43.1 Acute Low Back Pain: Red Flags, Strain & Disc Herniation 43.2 Acute Cervical Strain, Whiplash & Axial Neck Pain 43.3 Evaluation of Falls in Ambulatory & Older Patients

44 Chapter 44: Acute Inflammatory Arthropathies & Generalized Pain

44.1 Acute Inflammatory Arthritis & Spondyloarthropathies 44.2 Myalgias, Rhabdomyolysis & Post-Viral Pain Syndromes 44.3 Acute Non-Headache Pain Management Strategies

45 Chapter 45: Acute Renal, Urinary & Genitourinary Conditions

45.1 Uncomplicated UTI, Pyelonephritis & Acute Urethritis 45.2 Hematuria Workup & Glomerulonephritis 45.3 Nephrolithiasis & Acute Urinary Tract Obstruction

46 Chapter 46: Acute Male Genitourinary & Prostatic Conditions

46.1 Acute Prostatitis, Epididymitis & Orchitis 46.2 Acute Scrotal Pain: Torsion vs Appendage, BPH & Male Genital Emergencies 46.3 Acute Urinary Retention & Incontinence Evaluation

47 Chapter 47: Acute Women's Health & Early Pregnancy Care

47.1 Early Pregnancy Diagnosis, Dating & Initial Complications 47.2 Abnormal Uterine Bleeding & Acute Menstrual Disorders 47.3 Premenstrual Syndrome & Premenstrual Dysphoric Disorder

48 Chapter 48: Breast Disorders, STIs & Pediatric Elimination

48.1 Palpable Breast Mass, Mastitis & Nipple Discharge 48.2 Sexually Transmitted Infections: Diagnosis, Staging & CDC Guidelines 48.3 Pediatric Enuresis & Encopresis

49 Chapter 49: Systemic Signs, Metabolic Dysregulation & Miscellaneous Infections

49.1 Acute Fever, Sepsis Screening & FUO in Primary Care 49.2 Acute Hyperglycemia & Symptomatic Hypoglycemia 49.3 Electrolyte Abnormalities: Mild-to-Moderate Disturbances 49.4 Vector-Borne, Tick-Borne & Rickettsial Illnesses

50 Chapter 50: Chronic Cardiovascular Diseases: Hypertension & Ischemia

50.1 Essential Hypertension Management: 2025 AHA/ACC Guideline & JNC Strategies 50.2 Chronic Coronary Artery Disease & Post-MI Secondary Prevention 50.3 Chronic Heart Failure: HFrEF, HFpEF & Quadruple GDMT

51 Chapter 51: Chronic Vascular, Valvular & Dyslipidemic Diseases

51.1 Peripheral Arterial Disease & Claudication 51.2 Chronic Valvular Heart Disease & Murmur Evaluation 51.3 Lipid Disorders & ASCVD Risk-Based Statin Therapy

52 Chapter 52: Chronic Respiratory Diseases: Asthma & COPD

52.1 Chronic Asthma Management: GINA Stepwise SMART Therapy 52.2 Chronic Obstructive Pulmonary Disease: GOLD Recommendations 52.3 Solitary Pulmonary Nodule Evaluation & Fleischner Society Criteria

53 Chapter 53: Chronic Metabolic Diseases: Diabetes Mellitus

53.1 Type 2 Diabetes Management: ADA Pharmacotherapy Algorithms 53.2 Type 1 Diabetes: Basal-Bolus Insulin, CGMs & Diabetic Complications 53.3 Diabetic Microvascular & Macrovascular Disease Surveillance

54 Chapter 54: Obesity, Nutrition & Metabolic Bone Diseases

54.1 Medical & Behavioral Management of Obesity & Incretin Mimetics 54.2 Osteoporosis & Metabolic Bone Disease: DEXA, FRAX & Antiresorptives 54.3 Nutritional Deficiencies: Vitamin D, B12, Iron & Malnutrition

55 Chapter 55: Chronic Endocrine Disorders

55.1 Primary & Subclinical Hypothyroidism, Hyperthyroidism & Nodules 55.2 Adrenal Disorders: Addison's Disease & Cushing's Syndrome 55.3 Hypercalcemia, Hyperparathyroidism & Pituitary Disorders

56 Chapter 56: Chronic Kidney Disease & Venous Disorders

56.1 Chronic Kidney Disease: KDIGO Staging & Renoprotective Therapy 56.2 Chronic Venous Insufficiency, Stasis Dermatitis & Lymphedema 56.3 Chronic Electrolyte & Acid-Base Management in CKD

57 Chapter 57: Chronic Gastrointestinal & Hepatic Diseases

57.1 Gastroesophageal Reflux Disease, Barrett's Esophagus & Dyspepsia 57.2 Chronic Liver Disease: MASLD/NAFLD, Cirrhosis & Portal Hypertension 57.3 Viral Hepatitis B & C: Long-Term Monitoring & DAA Therapy

58 Chapter 58: Colorectal Surveillance & Chronic Pancreaticobiliary Care

58.1 Post-Polypectomy Colorectal Polyp Surveillance Guidelines 58.2 Chronic Pancreatitis & Exocrine Pancreatic Insufficiency 58.3 Chronic Nausea, Gastroparesis & Functional GI Disorders

59 Chapter 59: Chronic Musculoskeletal & Rheumatologic Disorders

59.1 Osteoarthritis: Hip, Knee & Hand Management 59.2 Spinal Conditions: Spinal Stenosis, Spondylolisthesis & Compression Fractures 59.3 Chronic Myopathies & Fibromyalgia Syndrome

60 Chapter 60: Chronic Neurologic & Neurodegenerative Disorders

60.1 Dementia: Alzheimer's, Vascular & Lewy Body Disease 60.2 Parkinson's Disease & Essential Tremor 60.3 Epilepsy: Chronic Antiseizure Medications & Post-Stroke Care

61 Chapter 61: Chronic Peripheral Nerves, Pain & Sensory Disorders

61.1 Diabetic & Chronic Peripheral Neuropathies 61.2 Chronic Pain Syndromes & Chronic Daily Headaches 61.3 Chronic Tinnitus, Presbycusis & Persistent Dizziness

62 Chapter 62: Chronic Psychiatric Disorders

62.1 Major Depressive Disorder & Generalized Anxiety Disorder 62.2 Bipolar Disorder: Maintenance Pharmacotherapy & Lithium Monitoring 62.3 Adult & Pediatric Attention-Deficit/Hyperactivity Disorder

63 Chapter 63: Chronic Behavioral Health & Neurodevelopmental Conditions

63.1 Chronic Behavioral Conditions: PTSD, OCD & Somatization 63.2 Autism Spectrum Disorder & Intellectual Disabilities 63.3 Eating Disorders: Anorexia Nervosa, Bulimia & Binge Eating

64 Chapter 64: Chronic Substance Use Disorders & Tobacco Cessation

64.1 Alcohol Use Disorder: Pharmacotherapy & Relapse Prevention 64.2 Opioid & Stimulant Use Disorders: MOUD & Harm Reduction 64.3 Longitudinal Tobacco Cessation Pharmacotherapy

65 Chapter 65: Chronic Dermatologic Conditions

65.1 Acne Vulgaris, Rosacea & Seborrheic Dermatitis 65.2 Chronic Plaque Psoriasis & Biologic Therapies 65.3 Chronic Eczema, Hidradenitis Suppurativa & Cutaneous Lupus

66 Chapter 66: Chronic Reproductive, Infectious & Geriatric Special Care

66.1 Chronic Menstrual Disorders, Infertility & Sexual Dysfunction 66.2 Menopause Management & Hormone Replacement Therapy 66.3 Chronic HIV Infection Management & Primary Care Integration 66.4 Gender-Affirming Primary Care & Hormone Therapy 66.5 Advance Care Planning, Palliative Care & End-of-Life Symptom Control

67 Chapter 67: Continuity Care: Sleep, Fatigue, Cancer, Pregnancy & the Adult Preventive Visit

67.1 Chronic Insomnia & Obstructive Sleep Apnea 67.2 Chronic Malaise, Fatigue & ME/CFS 67.3 Primary Care During Cancer Treatment & Survivorship 67.4 Routine Prenatal Care & Longitudinal Pregnancy Management 67.5 The Periodic Adult Health Examination & Medicare Annual Wellness Visit

34.2 Acute Constipation & Functional Bowel Changes

Key Takeaways Explain This Topic AI

Acute constipation (<3 months) or any new-onset change in bowel habits in patients aged ≥45-50 years, or accompanied by red flag alarm symptoms (unintentional weight loss, hematochezia, iron deficiency anemia, family history of CRC), warrants prompt structural evaluation with colonoscopy to exclude colorectal malignancy.

Secondary etiologies must be systematically screened: common offenders include medications (opioids, anticholinergics, calcium channel blockers, oral iron, TCAs), metabolic derangements (hypothyroidism, hypercalcemia, hypokalemia, diabetes mellitus), and neurologic disorders (Parkinson disease, spinal cord injury).

Digital rectal examination (DRE) is an essential diagnostic maneuver: it detects fecal impaction, assesses resting anal sphincter tone, identifies pelvic masses or strictures, and distinguishes slow-transit constipation from pelvic floor dyssynergia (paradoxical puborectalis contraction during simulated evacuation).

Acute fecal impaction must be resolved mechanically before initiating oral laxatives; first-line management requires digital fragmentation and disimpaction under generous lubrication, followed by mineral oil or warm water retention enemas; sodium phosphate enemas should be avoided in elderly or renal patients due to acute phosphate nephropathy.

The evidence-based pharmacologic laxative hierarchy begins with bulk-forming fibers (psyllium, methylcellulose) and osmotic agents (polyethylene glycol 3350), progressing to stimulant laxatives (senna, bisacodyl), intestinal secretagogues (lubiprostone, linaclotide), and peripheral mu-opioid receptor antagonists (PAMORAs: methylnaltrexone, naloxegol) specifically for opioid-induced constipation.

Last updated: September 2026

Definition, Epidemiology & Rome IV Diagnostic Criteria

Constipation is one of the most frequent gastrointestinal complaints encountered in ambulatory family medicine, accounting for over 8 million physician visits annually in the United States. Clinically, patients describe constipation with heterogeneous complaints: excessive straining, hard or lumpy stools, infrequent defecation, an inability to pass stool, or a persistent sensation of incomplete rectal evacuation.

Clinical Staging: Acute vs. Chronic

Acute Constipation (<3 Months Duration) : Sudden, new-onset reduction in bowel movement frequency or sudden change in stool consistency. In an adult aged ≥45 to 50 years, acute constipation must be presumed to be secondary to an identifiable organic or structural cause (such as obstructing neoplasia, new medication, or metabolic derangement) until proven otherwise.

Chronic Constipation (≥6 Months Total Duration with Active Symptoms for ≥3 Months) : Reflects underlying disordered motility, functional defecatory disorders, or long-standing lifestyle factors.

The Bristol Stool Form Scale (BSFS)

The Bristol Stool Form Scale is the validated clinical reference standard for assessing intestinal transit time:

Type 1 : Separate hard lumps, like nuts (hard to pass; indicates severely delayed transit).

Type 2 : Sausage-shaped but lumpy (indicates slow transit and constipation).

Type 3 : Like a sausage but with cracks on its surface (normal).

Type 4 : Like a sausage or snake, smooth and soft (normal; ideal stool form).

Type 5 : Soft blobs with clear-cut edges (passed easily; indicates rapid transit).

Type 6 : Fluffy pieces with ragged edges, a mushy stool (mild diarrhea).

Type 7 : Watery, no solid pieces, entirely liquid (severe diarrhea).

Rome IV Diagnostic Criteria for Functional Constipation

To fulfill the Rome IV criteria, symptoms must have started at least 6 months prior to diagnosis and must be actively present for the last 3 months, fulfilling two or more of the following criteria in at least 25% of defecations:

• Straining during more than one-fourth (25%) of defecations;
• Lumpy or hard stools (Bristol Stool Scale Types 1 or 2) in more than one-fourth of defecations;
• Sensation of incomplete evacuation for more than one-fourth of defecations;
• Sensation of anorectal obstruction or blockage for more than one-fourth of defecations;

Manual maneuvers to facilitate defecations (e.g., digital evacuation, support of the pelvic floor) in more than one-fourth of defecations;

Fewer than three spontaneous bowel movements per week . Diagnostic Exclusion : Loose stools must rarely be present without the use of laxatives, and there must be insufficient criteria for Irritable Bowel Syndrome with Constipation (IBS-C). IBS-C is distinguished from functional constipation by the presence of recurrent abdominal pain (at least 1 day per week in the last 3 months) that is temporally related to defecation and associated with a change in stool frequency or form.

Secondary Etiologies of Acute Constipation: The Diagnostic Differential

When a patient presents with acute constipation or a new-onset change in bowel habits, the clinician must systematically exclude secondary, reversible causes across four major categories:

Comprehensive Etiology & Differential Breakdown

Category Specific Offending Etiologies Underlying Pathophysiologic Mechanism Diagnostic Clues & Pearls

Medications • Opioids (oxycodone, morphine, fentanyl, tramadol); • Anticholinergics (diphenhydramine, oxybutynin, tolterodine); • Tricyclic Antidepressants (amitriptyline, nortriptyline); • Antipsychotics (clozapine, olanzapine); • Calcium Channel Blockers (verapamil > diltiazem); • Cation Supplements (ferrous sulfate, calcium carbonate); • 5-HT3 Antagonists (ondansetron) • Opioids stimulate enteric mu-receptors, arresting peristalsis and enhancing fluid absorption; • Anticholinergics block muscarinic M3 receptors on colonic smooth muscle; • CCBs inhibit L-type calcium channels, reducing smooth muscle contractility; • Iron/calcium bind water and alter stool consistency History of recent surgery, injury, pain management, psychiatric therapy, or anemia treatment. Verapamil has the highest rate of severe constipation among antihypertensive agents (up to 30%). Clozapine carries an FDA black box warning for fatal gastrointestinal hypomotility/ileus.

Metabolic & Endocrine • Hypothyroidism ; • Hypercalcemia (primary hyperparathyroidism, malignancy); • Hypokalemia (diuretic overuse, vomiting); • Diabetes Mellitus ; • Uremia / End-Stage Renal Disease • Thyroid hormone deficiency blunts enteric smooth muscle basal metabolic activity; • Hypercalcemia reduces neuromuscular excitability and smooth muscle depolarization; • Hypokalemia hyperpolarizes cell membranes, inducing paralytic hypomotility; • Long-standing diabetes induces enteric autonomic neuropathy Serum TSH, basic metabolic panel (calcium, potassium, creatinine), and fasting glucose/HbA1c provide rapid screening. Hypercalcemia presents with 'stones, bones, abdominal groans, and psychic moans.'

Mechanical & Structural Obstruction • Colorectal Adenocarcinoma ; • Benign Strictures (diverticulitis, ischemia, radiation, Crohn's); • Volvulus (sigmoid volvulus in elderly, cecal volvulus); • Extrinsic Compression (pelvic mass, ovarian cancer, fibroids); • Rectocele / Rectal Prolapse Physical narrowing of the colonic lumen preventing passage of the fecal bolus; rectocele causes stool entrapment within the anterior rectal wall Left-sided 'napkin-ring' annular colonic carcinomas present with pencil-thin caliber stools, progressive obstipation, and hematochezia. Sigmoid volvulus presents with massive asymmetric abdominal distension and 'coffee-bean' sign on radiograph.

Neurologic & Neuromuscular • Parkinson Disease ; • Spinal Cord Lesions (transverse myelitis, MS, compression); • Cauda Equina Syndrome ; • Autonomic Neuropathy ; • Adult Hirschsprung Disease (short-segment) Loss of extrinsic parasympathetic innervation (vagus/pelvic splanchnic) or intrinsic myenteric/submucosal plexus degeneration (Lewy body alpha-synuclein deposition in Parkinson's) Parkinson disease frequently manifests constipation years before motor tremors develop. Cauda equina presents with saddle anesthesia, urinary retention, and loss of anal sphincter tone—mandating emergency MRI spine.

Alarm Red Flags Mandating Urgent Structural Evaluation

Routine diagnostic colonoscopy is not indicated for chronic functional constipation in young patients without alarm features. However, the presence of any single alarm red flag mandates urgent structural evaluation (typically diagnostic colonoscopy or cross-sectional contrast-enhanced CT of the abdomen and pelvis) to rule out malignancy or high-grade luminal stricture: ACUTE CONSTIPATION: ALARM RED FLAGS

• PATIENT DEMOGRAPHICS & HISTORY CLINICAL & LABORATORY HALLMARKS
• Age >=45 to 50 years with new- • Unintentional weight loss (>=5% in 6-12 mo)
• onset acute change in bowel habit • Overt hematochezia, melena, or positive FIT
• Family history of colorectal cancer • Unexplained microcytic iron deficiency anemia
• or inflammatory bowel disease • Persistent nausea, vomiting, obstipation
• Severe, progressive, localized, or • Palpable abdominal or rectal mass
• nocturnal abdominal pain • Refractory to multi-class laxative therapy

Age ≥45 to 50 Years : USPSTF and ACG guidelines establish age 45 as the threshold for average-risk colorectal cancer screening. Any patient in this age cohort presenting with an acute, unexplained alteration in bowel frequency, stool caliber ("pencil stools"), or persistent constipation warrants full structural colonoscopy.

Iron Deficiency Anemia (IDA) : Microcytic hypochromic anemia (low hemoglobin, low ferritin, high TIBC) in an adult or postmenopausal woman is colorectal cancer until proven otherwise. A negative stool occult blood test never excludes malignancy.

Obstipation : Inability to pass either stool or flatus. When accompanied by acute abdominal distension, tympany, and vomiting, it signals high-grade or complete mechanical bowel obstruction.

Focused Physical Examination & Digital Rectal Examination (DRE)

A thorough physical examination is mandatory in all patients presenting with acute constipation. Omitting the digital rectal examination is a leading cause of diagnostic error and missed fecal impaction.

Abdominal Examination

Inspection : Observe for generalized abdominal distension, asymmetric bulges (sigmoid volvulus), or prior surgical laparotomy scars (predisposing to adhesive small bowel obstruction).

Auscultation : High-pitched, hyperactive metallic tinkling "rushes" suggest mechanical obstruction; completely absent bowel sounds suggest diffuse paralytic ileus or peritonitis.

Palpation & Percussion : Palpate for focal tenderness, voluntary or involuntary guarding, peritoneal signs, or a firm, mobile, sausage-shaped stool-loaded colon in the left lower quadrant. Percuss for tympany over gaseous colonic loops.

Perianal Inspection & Anorectal Examination

With the patient in the left lateral decubitus position (Sims position) with knees flexed, separate the buttocks and inspect under direct illumination:

Look for perianal excoriations, erythema, external hemorrhoids, anal fissures (especially posterior midline), skin tags, and anal fistulas.

Perineal Descent Assessment : Observe the perineum at rest and ask the patient to strain/bear down. Normal perineal descent is 1 to 3 cm. Descent <1 cm suggests pelvic floor hypertonicity; descent >3 to 4 cm indicates excessive pelvic floor laxity and perineal descent syndrome.

Anocutaneous Reflex ("Anal Wink") : Gently stroke the perianal skin in all four quadrants with a cotton swab. A normal response is reflex contraction of the external anal sphincter (mediated via pudendal nerve afferents and efferents, S2-S4). Absence of the anal wink suggests sacral cord or pudendal nerve neuropathy.

Digital Rectal Examination (DRE) Technique & Clinical Findings

Insert a well-lubricated, gloved index finger gently through the anal canal:

Resting Sphincter Tone : Evaluates the internal anal sphincter (which supplies 70-85% of resting tone). A hypertonic, tight, spastic sphincter suggests anal fissure or proctalgia fugax; a patulous, hypotonic sphincter suggests pudendal nerve injury, multiparity, or neurologic lesion (risk of fecal incontinence).

Voluntary Squeeze Pressure : Ask the patient to squeeze the sphincter around the examining finger. Assesses external anal sphincter and puborectalis motor function (somatic innervation).

Assessment for Fecal Impaction & Masses : Sweep the finger 360 degrees through the rectal ampulla to palpate for hard, rock-like, desiccated fecal masses (fecal impaction), mucosal ulcerations, extraluminal pelvic masses (e.g., Blumer's shelf in gastric/ovarian metastases), or strictures.

Simulated Evacuation Test (Pelvic Floor Dyssynergia / Anismus Assessment) :

While the finger remains in the anal canal, instruct the patient to "bear down as if attempting to push out a bowel movement."

Normal Response : The patient increases intra-abdominal pressure, the puborectalis muscle relaxes, the external anal sphincter relaxes (finger senses sphincter loosening), and the perineum gently descends 1 to 3 cm.

Pelvic Floor Dyssynergia (Dyssynergic Defecation) : The patient paradoxically contracts the external anal sphincter and puborectalis muscle (the finger feels gripped more tightly) OR fails to achieve >20% relaxation of the anal sphincter, combined with inadequate intra-abdominal propulsive force.

Clinical Significance : Dyssynergic defecation accounts for up to 30% to 50% of patients with chronic refractory constipation. It is confirmed by anorectal manometry and balloon expulsion testing (inability to expel a 50-mL water-filled balloon within 1-2 minutes). Crucially, pelvic floor dyssynergia does NOT respond to standard laxatives ; the definitive, evidence-based treatment of choice is anorectal pelvic floor biofeedback physical therapy .

Acute Fecal Impaction: Emergency Bedside Protocol

Fecal impaction is the accumulation and compaction of hardened, desiccated, rock-like fecal matter in the rectal ampulla or colon that cannot be spontaneously evacuated.

Clinical Presentation & The Trap of "Bypass Diarrhea"

Most common in frail, institutionalized elderly patients, individuals with severe dementia or Parkinson disease, and patients receiving high-dose scheduled opioids.

Patients present with lower abdominal fullness, crampy pain, anorexia, nausea, urinary retention (mass effect of the distended rectum compressing the bladder neck), and frequent, small-volume, foul-smelling liquid stool leakage (encopresis / "spurious bypass diarrhea") .

Crucial Diagnostic Trap : Clinicians frequently misdiagnose spurious bypass diarrhea as infectious or antibiotic-associated diarrhea and mistakenly prescribe loperamide or antimotility agents, transforming a manageable impaction into life-threatening stercoral ulceration, ischemic colonic necrosis, and stercoral perforation !

Stepwise Management Protocol ACUTE FECAL IMPACTION MANAGEMENT

• STEP 1: MANUAL DIGITAL DISIMPACTION
• Generous water-soluble lubrication or 2% lidocaine jelly
• Gently introduce gloved index finger into rectum
• Scissor-like digital fragmentation of the rock-hard mass
• Extract fragmented fecal material manually

• STEP 2: ENEMA THERAPY FOR RESIDUAL PROXIMAL STOOL
• Mineral oil retention enema (100 to 200 mL) to lubricate & soften
• Follow 1 to 2 hours later with warm tap-water or saline enema

• AVOID Sodium Phosphate (Fleet) enemas in elderly / CKD!

• STEP 3: MAINTENANCE REGIMEN TO PREVENT RECURRENCE
• Initiate daily oral Polyethylene Glycol (PEG 3350) 17 g daily
• Ensure adequate daily fluid intake and scheduled toilet routines

• Never administer oral stimulant laxatives BEFORE impaction is cleared!

Caution

BLACK BOX SAFETY WARNING: AVOID SODIUM PHOSPHATE (FLEET) ENEMAS IN VULNERABLE POPULATIONS Sodium phosphate enemas are hypertonic and draw water rapidly into the bowel lumen. In elderly patients, patients with chronic kidney disease (CKD), congestive heart failure, or bowel motility disorders, excessive transmucosal phosphate absorption causes severe hyperphosphatemia, profound hypocalcemia, tetany, refractory cardiac arrhythmias, and acute phosphate nephropathy (irreversible renal failure) . Always utilize mineral oil retention enemas or warm tap-water / normal saline enemas instead.

Loading diagram... Stepwise Diagnostic and Treatment Algorithm for Acute Constipation